View in EDS HTML Full Text PDF Full Text

A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.

Saved in:
Bibliographic Details
Title: A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.
Authors: Yurgelun-Todd, Deborah A.1 (AUTHOR) Deborah.Yurgelun-Todd@hsc.utah.edu, Renshaw, Perry F.1 (AUTHOR), Goldsmith, Paul2 (AUTHOR), Uz, Tolga3 (AUTHOR), Macek, Thomas A.3 (AUTHOR)
Source: Psychopharmacology. Feb2020, Vol. 237 Issue 2, p317-328.
Database: SPORTDiscus with Full Text
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: s3h
DbLabel: SPORTDiscus with Full Text
An: 141727124
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Yurgelun-Todd%2C+Deborah+A%2E%22">Yurgelun-Todd, Deborah A.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Deborah.Yurgelun-Todd@hsc.utah.edu</i><br /><searchLink fieldCode="AR" term="%22Renshaw%2C+Perry+F%2E%22">Renshaw, Perry F.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Goldsmith%2C+Paul%22">Goldsmith, Paul</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Uz%2C+Tolga%22">Uz, Tolga</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Macek%2C+Thomas+A%2E%22">Macek, Thomas A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Psychopharmacology%22">Psychopharmacology</searchLink>. Feb2020, Vol. 237 Issue 2, p317-328.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=s3h&AN=141727124
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s00213-019-05366-1
    Languages:
      – Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 12
        StartPage: 317
    Titles:
      – TitleFull: A randomized, placebo-controlled, phase 1 study to evaluate the effects of TAK-063 on ketamine-induced changes in fMRI BOLD signal in healthy subjects.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Yurgelun-Todd, Deborah A.
      – PersonEntity:
          Name:
            NameFull: Renshaw, Perry F.
      – PersonEntity:
          Name:
            NameFull: Goldsmith, Paul
      – PersonEntity:
          Name:
            NameFull: Uz, Tolga
      – PersonEntity:
          Name:
            NameFull: Macek, Thomas A.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: Feb2020
              Type: published
              Y: 2020
          Identifiers:
            – Type: issn-print
              Value: 00333158
          Numbering:
            – Type: volume
              Value: 237
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Psychopharmacology
              Type: main
ResultId 1